These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29641321)

  • 1. A Calsequestrin Cis-Regulatory Motif Coupled to a Cardiac Troponin T Promoter Improves Cardiac Adeno-Associated Virus Serotype 9 Transduction Specificity.
    Chamberlain K; Riyad JM; Garnett T; Kohlbrenner E; Mookerjee A; Elmastour F; Benard L; Chen J; VandenDriessche T; Chuah MK; Marian AJ; Hajjar RJ; Gurha P; Weber T
    Hum Gene Ther; 2018 Aug; 29(8):927-937. PubMed ID: 29641321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of heart ischemia and administration route on biodistribution and transduction efficiency of AAV9 vectors.
    García-Olloqui P; Rodriguez-Madoz JR; Di Scala M; Abizanda G; Vales Á; Olagüe C; Iglesias-García O; Larequi E; Aguado-Alvaro LP; Ruiz-Villalba A; Prosper F; Gonzalez-Aseguinolaza G; Pelacho B
    J Tissue Eng Regen Med; 2020 Jan; 14(1):123-134. PubMed ID: 31677236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing atrial-specific gene expression using a calsequestrin cis-regulatory module 4 with a sarcolipin promoter.
    Yoo J; Kohlbrenner E; Kim O; Hajjar RJ; Jeong D
    J Gene Med; 2018 Dec; 20(12):e3060. PubMed ID: 30393908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
    Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
    Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting transgene to the heart and liver with AAV9 by different promoters.
    Chen BD; He CH; Chen XC; Pan S; Liu F; Ma X; Li XM; Gai MT; Tao J; Ma YT; Yang YN; Gao XM
    Clin Exp Pharmacol Physiol; 2015 Oct; 42(10):1108-17. PubMed ID: 26173818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial-Specific Gene Delivery Using an Adeno-Associated Viral Vector.
    Ni L; Scott L; Campbell HM; Pan X; Alsina KM; Reynolds J; Philippen LE; Hulsurkar M; Lagor WR; Li N; Wehrens XHT
    Circ Res; 2019 Jan; 124(2):256-262. PubMed ID: 30582449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid and highly efficient inducible cardiac gene knockout in adult mice using AAV-mediated expression of Cre recombinase.
    Werfel S; Jungmann A; Lehmann L; Ksienzyk J; Bekeredjian R; Kaya Z; Leuchs B; Nordheim A; Backs J; Engelhardt S; Katus HA; Müller OJ
    Cardiovasc Res; 2014 Oct; 104(1):15-23. PubMed ID: 25082846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term preservation of cardiac structure and function after adeno-associated virus serotype 9-mediated microdystrophin gene transfer in mdx mice.
    Schinkel S; Bauer R; Bekeredjian R; Stucka R; Rutschow D; Lochmüller H; Kleinschmidt JA; Katus HA; Müller OJ
    Hum Gene Ther; 2012 Jun; 23(6):566-75. PubMed ID: 22248393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA122-regulated transgene expression increases specificity of cardiac gene transfer upon intravenous delivery of AAV9 vectors.
    Geisler A; Jungmann A; Kurreck J; Poller W; Katus HA; Vetter R; Fechner H; Müller OJ
    Gene Ther; 2011 Feb; 18(2):199-209. PubMed ID: 21048795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AAV-9 mediated phosphatase-1 inhibitor-1 overexpression improves cardiac contractility in unchallenged mice but is deleterious in pressure-overload.
    Schwab DM; Tilemann L; Bauer R; Heckmann M; Jungmann A; Wagner M; Burgis J; Vettel C; Katus HA; El-Armouche A; Müller OJ
    Gene Ther; 2018 Jan; 25(1):13-19. PubMed ID: 29350681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single direct injection into the left ventricular wall of an adeno-associated virus 9 (AAV9) vector expressing extracellular superoxide dismutase from the cardiac troponin-T promoter protects mice against myocardial infarction.
    Prasad KM; Smith RS; Xu Y; French BA
    J Gene Med; 2011 Jun; 13(6):333-41. PubMed ID: 21674736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide computational analysis reveals cardiomyocyte-specific transcriptional Cis-regulatory motifs that enable efficient cardiac gene therapy.
    Rincon MY; Sarcar S; Danso-Abeam D; Keyaerts M; Matrai J; Samara-Kuko E; Acosta-Sanchez A; Athanasopoulos T; Dickson G; Lahoutte T; De Bleser P; VandenDriessche T; Chuah MK
    Mol Ther; 2015 Jan; 23(1):43-52. PubMed ID: 25195597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac-selective expression of extracellular superoxide dismutase after systemic injection of adeno-associated virus 9 protects the heart against post-myocardial infarction left ventricular remodeling.
    Konkalmatt PR; Beyers RJ; O'Connor DM; Xu Y; Seaman ME; French BA
    Circ Cardiovasc Imaging; 2013 May; 6(3):478-86. PubMed ID: 23536266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adeno-associated virus serotype 9 efficiently targets ischemic skeletal muscle following systemic delivery.
    Katwal AB; Konkalmatt PR; Piras BA; Hazarika S; Li SS; John Lye R; Sanders JM; Ferrante EA; Yan Z; Annex BH; French BA
    Gene Ther; 2013 Sep; 20(9):930-8. PubMed ID: 23535898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuraminidase-mediated desialylation augments AAV9-mediated gene expression in skeletal muscle.
    Zhu H; Wang T; John Lye R; French BA; Annex BH
    J Gene Med; 2018 Sep; 20(9):e3049. PubMed ID: 30101537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exogenous control of cardiac gene therapy: evidence of regulated myocardial transgene expression after adenovirus and adeno-associated virus transfer of expression cassettes containing corticosteroid response element promoters.
    Lee LY; Zhou X; Polce DR; El-Sawy T; Patel SR; Thakker GD; Narumi K; Crystal RG; Rosengart TK
    J Thorac Cardiovasc Surg; 1999 Jul; 118(1):26-4, discussion 34-5. PubMed ID: 10384181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic and Persistent Muscle Gene Expression in Rhesus Monkeys with a Liver De-Targeted Adeno-Associated Virus Vector.
    Tarantal AF; Lee CCI; Martinez ML; Asokan A; Samulski RJ
    Hum Gene Ther; 2017 May; 28(5):385-391. PubMed ID: 28125921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors.
    Raake PW; Hinkel R; Müller S; Delker S; Kreuzpointner R; Kupatt C; Katus HA; Kleinschmidt JA; Boekstegers P; Müller OJ
    Gene Ther; 2008 Jan; 15(1):12-7. PubMed ID: 17943147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robust cardiomyocyte-specific gene expression following systemic injection of AAV: in vivo gene delivery follows a Poisson distribution.
    Prasad KM; Xu Y; Yang Z; Acton ST; French BA
    Gene Ther; 2011 Jan; 18(1):43-52. PubMed ID: 20703310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential myocardial gene delivery by recombinant serotype-specific adeno-associated viral vectors.
    Du L; Kido M; Lee DV; Rabinowitz JE; Samulski RJ; Jamieson SW; Weitzman MD; Thistlethwaite PA
    Mol Ther; 2004 Sep; 10(3):604-8. PubMed ID: 15336660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.